Safe and effective use of phototherapy and photochemotherapy in the treatment of psoriasis.

Psoriasis is a chronic, multisystem inflammatory disease, predominantly affecting the skin and joints, which is present in 2-3% of the world's population. Narrow band ultraviolet B (NB-UVB) and Psoralen + ultraviolet A (PUVA) are recognised, effective and, in the case of UVB, economical second-line treatments for psoriasis where topical therapies fail to control the disease or are an impracticable option due to the extent of skin involvement. This article examines the history of phototherapy and photochemotherapy and looks at current phototherapy treatments used for psoriasis. It discusses side effects of treatment and regimens that can be followed to increase effectiveness of treatment and minimise risks. The role of the nurse phototherapist is also discussed.

[1]  S. Ibbotson,et al.  Narrowband ultraviolet B treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments , 2018, The British journal of dermatology.

[2]  S. Ibbotson.  A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy , 2018, Front. Med..

[3]  S. Ibbotson,et al.  Narrowband UVB treatment is highly effective and causes a strong reduction in the use of steroid and other creams in psoriasis patients in clinical practice , 2017, PloS one.

[4]  S. Ibbotson,et al.  University of Dundee British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015 , 2017 .

[5]  B. N. Akay,et al.  Narrowband ultraviolet B phototherapy starting and incremental dose in patients with psoriasis: comparison of percentage dose and fixed dose protocols , 2015, Photodermatology, photoimmunology & photomedicine.

[6]  W. Liao,et al.  Phototherapy in Psoriasis: A Review of Mechanisms of Action , 2013, Journal of cutaneous medicine and surgery.

[7]  H. Hönigsmann,et al.  History of phototherapy in dermatology , 2012, Photochemical & Photobiological Sciences.

[8]  S. Ibbotson,et al.  A randomized comparison of methods of selecting narrowband UV-B starting dose to treat chronic psoriasis. , 2011, Archives of dermatology.

[9]  S. Ong,et al.  Legal claims in English dermatological practice , 2011, The British journal of dermatology.

[10]  R. Dawe,et al.  Incidence of skin cancers in 3867 patients treated with narrow‐band ultraviolet B phototherapy , 2008, The British journal of dermatology.

[11]  B. Diffey,et al.  An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report , 2004, The British journal of dermatology.

[12]  A. Drummond,et al.  Legal claims in Scottish National Health Service Dermatology Departments 1989–2001 , 2003, The British journal of dermatology.

[13]  S. Ibbotson,et al.  A randomized controlled trial of narrowband ultraviolet B vs. bath‐psoralen plus ultraviolet A photochemotherapy for psoriasis , 2003, The British journal of dermatology.

[14]  S. Rogers,et al.  Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. , 2003, Archives of dermatology.

[15]  S. Ibbotson,et al.  A randomized, observer‐blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis , 2002, The British journal of dermatology.

[16]  H. Cameron,et al.  Photosensitizing drugs may lower the narrow‐band ultraviolet B (TL‐01) minimal erythema dose , 2000, The British journal of dermatology.

[17]  B. Diffey,et al.  Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group , 2000, The British journal of dermatology.

[18]  Cameron,et al.  Narrow‐band (TL‐01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? , 1998, The British journal of dermatology.

[19]  J. C. Leun,et al.  A new development in UVB phototherapy of psoriasis , 1988, The British journal of dermatology.

[20]  E. Snellman,et al.  Randomized half-side comparison of narrowband UVB and trimethylpsoralen bath plus UVA treatments for psoriasis. , 2004, Acta dermato-venereologica.